ELOXX PHARMACEUTICALS, INC. — Revenue by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/6dcde7ac-3894-4348-ad60-e87bf924bc51/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $0 | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-108687 |
| FY 2024 | $6.4M | 2024-01-01 – 2024-12-31 | evidence 0001193125-26-108687 |
| FY 2023 | $0 | 2023-01-01 – 2023-12-31 | evidence 0001193125-26-108687 |
| FY 2014 | $182.2k | 2013-07-01 – 2014-06-30 | evidence 0001144204-14-058176 |
| FY 2013 | $7.8k | 2012-07-01 – 2013-06-30 | evidence 0001144204-14-058176 |
| FY 2012 | $1.8M | 1998-07-01 – 2012-12-31 | evidence 0001144204-13-008524 |
| FY 2011 | $1.8M | 1998-07-01 – 2012-03-31 | evidence 0001144204-12-028430 |
| FY 2010 | $140.0k | 2009-07-01 – 2010-06-30 | evidence 0001144204-12-057875 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ELOXX PHARMACEUTICALS, INC. — all facts · Net Income · Operating Income